1313425-86-3

Upstream product

• 1313425-10-3 8-benzyl-7-methyl-5-oxo-6-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid methyl ester 
• 1313425-03-4 8-benzyl-6-iodo-7-methyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid methyl ester 
• 1313424-94-0 8-benzyl-7-methyl-5-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyridine-3-carboxylic acid methyl ester 
• 1313424-83-7 methyl 2-phenethyl-4,5-dihydrothiazole-4-carboxylate 
• 1313425-70-5 8-benzyl-3-hydroxymethyl-7-methyl-6-phenyl-2,3-dihydro-5H-thiazolo[3,2-a]pyridin-5-one 
• 52353-64-7 ethyl 3-phenylpropionimidate hydrochloride 
• 645-59-0 dihydrocinnamonitrile 

Downstream Products

• 1313418-94-8 8-benzyl-3-(benzylaminomethyl)-7-methyl-6-phenyl-2,3-dihydro-thiazolo[3,2-a]pyridin-5-one 

Relevant academic research and scientific papers

PYRIDINONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF

Pyridinone derivatives, process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially sex-hormone-related conditions in both men and women, as well as a mammal in general (also referred to herein as a "subject"). For example, such conditions include endometriosis, uterine fibroids, polycystic ovarian disease, heavy menstrual bleeding, particularly menorrahagia and dysmenorrehea, hirsutism, precocious puberty, gonadal steroid-dependent neoplasia such as cancers of the prostate, breast and ovary, gonadotrope pituitary adenomas, sleep apnea, irritable bowel syndrome, premenstrual syndrome, benign prostatic hypertrophy, contraception and infertility (e.g., assisted reproductive therapy such as in vitro fertilization). The present application relates in particular to pyridinone derivatives as gonadotropin-releasing hormone (GnRH) receptor antagonists.